Home OCT Monitoring as a Safety Net for Early Detection of Recurrent Disease Activity in Neovascular Age-Related Macular Degeneration Under Standard Care. [PDF]
Sambhara D, Abbey AM, Eichenbaum DA.
europepmc +1 more source
Two-year real-world effectiveness of faricimab after treatment switch in neovascular age-related macular degeneration. [PDF]
Ruiz-Medrano J +3 more
europepmc +1 more source
A Novel Ocular Fibrosis Signature for AMD Using the Two-Stage Laser-Induced Subretinal Fibrosis Mouse Model. [PDF]
Hughes D +8 more
europepmc +1 more source
Tyrosine Kinase Receptors, Inhibition, and Potential Role in the Pharmacotherapy of Retinal Disorders. [PDF]
Venkatesh P.
europepmc +1 more source
Association of Vortex Vein Morphology with Punctate Hyperfluorescence on ICGA in Neovascular Age-Related Macular Degeneration. [PDF]
Kamao H +5 more
europepmc +1 more source
From Subretinal to Intraretinal Fluid in Type 1 Macular Neovascularization: A Clinicopathologic Disease Transition Model. [PDF]
Cicinelli MV +5 more
europepmc +1 more source
Serum microRNA-34a as a circulating biomarker for age-related macular degeneration and short-term anti-VEGF response in neovascular AMD. [PDF]
Kong M, Jin R, Cheng T, Sun L, Tong N.
europepmc +1 more source
Baseline Biomarkers Associated with Early Anatomical Response After Faricimab Loading Therapy in Treatment-Naïve Neovascular Age-Related Macular Degeneration. [PDF]
Ikeuchi E +4 more
europepmc +1 more source
Machine Learning Accelerated Non-Adiabatic Molecular Dynamics Elucidates Local Polarization Effects on Non-radiative Recombination in Halide Perovskites. [PDF]
Yang B +13 more
europepmc +1 more source
Comparative efficacy and safety of Ranibizumab and Aflibercept for neovascular age-related macular degeneration: a systematic review and meta-analysis. [PDF]
Zhao X, Yang Y.
europepmc +1 more source

